학술논문
S214: DISEASE‐MODIFYING ACTIVITY OF NAVTEMADLIN (NVTM) CORRELATED WITH SURVIVAL OUTCOMES IN JANUS KINASE INHIBITOR (JAKI) RELAPSED OR REFRACTORY (R/R) MYELOFIBROSIS (MF) PATIENTS (PTS)
Document Type
Article
Author
Vachhani, Pankit; Perkins, Andrew; Mascarenhas, John; Al‐Ali, Haifa Kathrin; Kiladjian, Jean‐Jacques; Cerquozzi, Sonia; Dybko, Jaroslaw; Delgado, Regina Garcia; Rivas, Jesus Hernández; Hebart, Holger; Huang, Zhuying; Krejsa, Cecile; Qamoos, Hope; Mcgreivy, Jesse; Rothbaum, Wayne P.; Verstovsek, Srdan; Vannucchi, Alessandro
Source
HemaSphere; 2023 Supplement 3, Vol. 7, p1-3, 3p
Subject
Language
ISSN
25729241